Webinar presentation: Change to classification of MDMA and psilocybin to enable prescribing by authorised psychiatrists

Presented by: Adj Prof Skerritt and Robyn Langham Therapeutic Goods Administration

Presented at: Online

Presentation date: Wednesday, 1 March 2023

Presentation summary: This webinar will address the recent announcement by the Therapeutic Goods Administration (TGA) that medicines containing psilocybin and MDMA will be classified as Schedule 8 (controlled drug) in the Poisons Standard for specific conditions when prescribed by a psychiatrist under the Authorised Prescriber scheme.